Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Cytek Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 88 | 103 | +15 |
| Shares | 61.0M | 64.1M | +3.02M (+4.9%) |
| Value | $898.5M | $654.1M | −$244.4M (−27.2%) |
New holders (25)
Institutions that held Cytek Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (10)
Institutions that held Cytek Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Brookfield Asset Management Inc. | 67,084 | $987.0K |
| Advisory Research Inc | 41,750 | $614.0K |
| Susquehanna International Group, LLP | 40,559 | $597.0K |
| Wellington Management Group LLP | 31,981 | $471.0K |
| AQR Capital Management LLC | 31,163 | $459.0K |
| State of Wisconsin Investment Board | 12,568 | $185.0K |
| Occudo Quantitative Strategies LP | 11,253 | $166.0K |
| Quantamental Technologies LLC | 10,040 | $148.0K |
| Ensign Peak Advisors, Inc | 7,210 | $106.0K |
| Crewe Advisors LLC | 77 | $1.00K |